BAK vs DOW

Braskem SA vs Dow Inc. — Valuation Comparison 2026

BAK

Chemicals
Braskem SA
Quality
5.5
out of 10
Value Trap
6
SAFE
Price
$4.46
Last close
Models
7/13
Active
VS

DOW

Chemicals
Dow Inc.
Quality
6.8
out of 10
Value Trap
20
SAFE
Price
$34.77
Last close
Models
12/13
Active

Model-by-Model Comparison

ModelType BAK Fair ValueBAK Upside DOW Fair ValueDOW Upside
Bayesian DCF Intrinsic $19.06 +327.4% $70.45 +102.6%
Earnings Power Value Intrinsic $11.95 -65.6%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $8.82 +97.7% $21.54 -38.1%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BAK vs DOW — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BAK vs DOW — Which Stock Is More Undervalued?

DOW scores higher with a 6.8/10 quality rating vs BAK's 5.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Braskem SA (BAK) and Dow Inc. (DOW) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BAK currently trades at $4.46 with a QOC of 5.5/10, while DOW trades at $34.77 with a QOC of 6.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).